The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતીमराठीবাংলাಕನ್ನಡമലയാളംதமிழ்తెలుగు
| 08 September, 2025, 05:20 PM IST | Today's ePaper
My Watchlist
Search
+
Business News›Prime›Pharma

Pharma

From near bankruptcy to blockbuster drug: How Khorakiwala turned around Wockhardt

Healthcare

10 mins readBy Vikas Dandekar & Rica Bhattacharyya
Ozempic, Wegovy, Mounjaro: Are GLP-1 drugs weight loss wonders or health gamble?

Healthcare

6 mins readBy Vid Karmarkar & Jitendra Chouksey
As Novo Nordisk scales back, Eris and Biocon Biologics hit the sweet spot in India’s insulin market

Healthcare

7 mins readBy Vikas Dandekar
India has a major health insurance headache

Under the lens

4 mins readBy MC Govardhana Rangan

Healthcare

How a genome map can help India fight cancer better
6 mins readBy Gayatri Devi & Abhishek Puri

Disease

What’s making GBS nerve disorder go viral in Pune
7 mins readBy Vikas Dandekar
This Ichnos Glenmark drug promises to BEAT cancer, affordably. Can it challenge Big Pharma?

Pharma

12 mins readBy Vikas Dandekar
Can Cipla win over diabetes patients with a painless, inhalable insulin?

Healthcare

8 mins readBy Vikas Dandekar
Where are PE players profiting in the healthcare sector?

Markets

6 mins readBy Vikas Dandekar & Priyanka Salve
Can herbs, starvation cure cancer? Sidhu flicks row, gets caught by Twitterati

Disease

9 mins readBy Vikas Dandekar
These bugs are killing 5 million every year, yet doctors have few options to fight them

Healthcare

These bugs are killing 5 million every year, yet doctors have few options to fight them
5 mins readBy Vikas Dandekar
What the headlong fall of 23andMe signals for India’s genetic-testing market

Healthcare

What the headlong fall of 23andMe signals for India’s genetic-testing market
6 mins readBy Vikas Dandekar
How fake drugs, Jan Aushadhi push are eating away the profits of top pharma companies

Healthcare

How fake drugs, Jan Aushadhi push are eating away the profits of top pharma companies
6 mins readBy Vikas Dandekar
The dark reality of melatonin behind India’s USD289 million wild chase for good sleep

Healthcare

The dark reality of melatonin behind India’s USD289 million wild chase for good sleep
9 mins readBy Kanika Saxena , Gauri Kaushik & Mitali Sharma

Pharma

Sun Pharma, Torrent, Alkem under lens for inferior medicines. It points to a leaky supply chain.
8 mins readBy Vikas Dandekar
Affordability is critical when it comes to patient care: GE HealthCare’s Sarawate

Healthcare

Affordability is critical when it comes to patient care: GE HealthCare’s Sarawate
7 mins readBy Vikas Dandekar
How rising awareness about infertility is making IVF a USD4.6 billion opportunity

Health

How rising awareness about infertility is making IVF a USD4.6 billion opportunity
7 mins readBy Abhishek Puri
Mpox virus is back. Is vaccine maker Serum Institute ready?

Disease

Mpox virus is back. Is vaccine maker Serum Institute ready?
8 mins readBy Vikas Dandekar
India must protect doctors. They are scarce, and it takes years to train one.

Healthcare

India must protect doctors. They are scarce, and it takes years to train one.
6 mins readBy Abhishek Puri & Mansak Shishak
Sun Pharma’s new drug to take on Pfizer, Eli Lilly is having a bad hair day.

Pharma

Sun Pharma’s new drug to take on Pfizer, Eli Lilly is having a bad hair day.
8 mins readBy Vikas Dandekar
Why leading doctors and scientists pin hope on green jackfruit to fight fatty liver and cancer

HealthcareFREE READ

Why leading doctors and scientists pin hope on green jackfruit to fight fatty liver and cancer
11 mins readBy Manu P Toms & Vikas Dandekar
This Ranjan Pai investment opens the door to a USD30 billion opportunity

Healthcare

This Ranjan Pai investment opens the door to a USD30 billion opportunity
9 mins readBy Garima Manon & Nirmal John
What an Indian pharma giant’s new drug find can gain the world’s obesity fight

Pharma

What an Indian pharma giant’s new drug find can gain the world’s obesity fight
6 mins readBy Vikas Dandekar
The Economic Times